Citation: Y. Gazitt, Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules, J HEMATH ST, 10(2), 2001, pp. 229-236
Citation: Y. Gazitt et al., Differential mobilization of CD34(+) cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors, J HEMATH ST, 10(1), 2001, pp. 167-176
Citation: Y. Gazitt et al., Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors, J HEMATH ST, 10(1), 2001, pp. 177-186
Citation: Y. Gazitt et al., Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors, STEM CELLS, 19(2), 2001, pp. 134-143
Citation: Y. Gazitt et Q. Liu, Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34(+) cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients, STEM CELLS, 19(1), 2001, pp. 37-45
Authors:
Kim, K
Takimoto, R
Dicker, DT
Chen, YH
Gazitt, Y
El-Deiry, WS
Citation: K. Kim et al., Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines, INT J ONCOL, 18(2), 2001, pp. 241-247
Citation: Q. Liu et al., Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines, EXP HEMATOL, 29(8), 2001, pp. 962-970
Authors:
Gazitt, Y
Reddy, SV
Alcantara, O
Yang, J
Boldt, DH
Citation: Y. Gazitt et al., A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: Iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate, J CELL PHYS, 187(1), 2001, pp. 124-135
Authors:
Anderson, JE
Tefferi, A
Craig, F
Holmberg, L
Chauncey, T
Appelbaum, FR
Guardiola, P
Callander, N
Freytes, C
Gazitt, Y
Razvillas, B
Deeg, HJ
Citation: Je. Anderson et al., Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis, BLOOD, 98(3), 2001, pp. 586-593
Authors:
Gazitt, Y
Callander, N
Freytes, CO
Shaughnessy, P
Liu, Q
Tsai, TW
Devore, P
Citation: Y. Gazitt et al., Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphomapatients: A randomized prospective study, J HEMATH ST, 9(5), 2000, pp. 737-748
Citation: Y. Gazitt et Q. Liu, High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34(+) PBSC in patients undergoing high-dose chemotherapy and stem cell rescue, J HEMATH ST, 9(2), 2000, pp. 285-293
Citation: Y. Gazitt, Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors, STEM CELLS, 18(6), 2000, pp. 390-398
Citation: Q. Liu et Y. Gazitt, Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes, EXP HEMATOL, 28(12), 2000, pp. 1354-1362
Authors:
Gazitt, Y
Freytes, CO
Callander, N
Tsai, TW
Alsina, M
Anderson, J
Holle, L
Cruz, J
Devoer, P
McGrath, M
West, G
Alvarez, R
Montgomery, W
Citation: Y. Gazitt et al., Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization, J HEMATOTH, 8(2), 1999, pp. 173-183
Citation: Y. Gazitt et al., Apoptosis-induced by trail and TNF-alpha in human multiple myeloma cells is not blocked by bcl-2, CYTOKINE, 11(12), 1999, pp. 1010-1019
Citation: Y. Gazitt, TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells, LEUKEMIA, 13(11), 1999, pp. 1817-1824
Authors:
Menaa, C
Devlin, RD
Reddy, SV
Gazitt, Y
Choi, SJ
Roodman, GD
Citation: C. Menaa et al., Annexin II increases osteoclast formation by stimulating the proliferationof osteoclast precursors in human marrow cultures, J CLIN INV, 103(11), 1999, pp. 1605-1613